324 filings
Page 11 of 17
8-K
7hfft3v7zh0cii
28 Apr 09
XIAFLEXTM for the Treatment of Dupuytren’s contracture Receives Priority Review from
12:00am
8-K
7fvpe agjtvqz
20 Mar 09
Departure of Directors or Certain Officers
12:00am
8-K
g9n3qtnre1cuxblcicsj
19 Mar 09
Regulation FD Disclosure
12:00am
8-K
r1q n78o14q1h
3 Mar 09
Auxilium Submits Biologics License Application for XIAFLEXTM for the Treatment of Dupuytren’s contracture to the U.S. Food and Drug Administration
12:00am
8-K
7sez53v6 pglw
18 Feb 09
Fourth Quarter and Full Year 2008 Financial Results, as well as Guidance for 2009
12:00am
8-K
s1wwulmq4 3u8
2 Feb 09
Auxilium Pharmaceuticals, Inc. Completes Enrollment in Phase IIb Clinical Trial of
12:00am
8-K
6rmvgkyl f8ilwju
21 Jan 09
Departure of Directors or Principal Officers
12:00am
8-K
nu5r lb2cos7
12 Jan 09
Regulation FD Disclosure
12:00am
8-K
zj01ho8
18 Dec 08
Entry into a Material Definitive Agreement
12:00am
8-K
jb7zoa 5ctevc28n5
4 Dec 08
Regulation FD Disclosure
12:00am
8-K
9ps5d 2snj6oh13lywwg
3 Dec 08
Regulation FD Disclosure
12:00am
8-K
nbc2hlhgv1dpqxs32e
1 Dec 08
Entry into a Material Definitive Agreement
12:00am
8-K
8aed3q9t8iowc7fpq09
30 Oct 08
Regulation FD Disclosure
12:00am
8-K
h2car0m85mng9ith3
29 Oct 08
Third Quarter 2008 Financial Results and Operational Highlights
12:00am
8-K
vc631 ci52
24 Oct 08
Regulation FD Disclosure
12:00am
8-K
dm6reiqs
7 Oct 08
Departure of Directors or Principal Officers
12:00am
8-K
116ru
1 Oct 08
First Amendment to Lease Agreement
12:00am
8-K
33g5vz
24 Sep 08
Regulation FD Disclosure
12:00am
8-K
sk74a0
3 Sep 08
Regulation FD Disclosure
12:00am
8-K
qey9lwmssaliy4m7a1xu
31 Jul 08
Second Quarter 2008 Financial Results and Operational Highlights
12:00am